U
Remedent, Inc.
REMI
$0.05
$0.000.00%
D
Sell
3/15/2022Downgrade
Remedent, Inc. (REMI) was downgraded to D from D+ on 3/15/2022 due to a decline in the total return index and volatility index.
Remedent, Inc. (REMI) was downgraded to D from D+ on 3/15/2022 due to a decline in the total return index and volatility index.
D
Sell
2/1/2022Upgraded
Remedent, Inc. (REMI) was upgraded to D+ from D on 2/1/2022 due to an increase in the volatility index, valuation index and efficiency index.
Remedent, Inc. (REMI) was upgraded to D+ from D on 2/1/2022 due to an increase in the volatility index, valuation index and efficiency index.
D
Sell
12/27/2021Downgrade
Remedent, Inc. (REMI) was downgraded to D from D+ on 12/27/2021 due to a decline in the total return index and valuation index.
Remedent, Inc. (REMI) was downgraded to D from D+ on 12/27/2021 due to a decline in the total return index and valuation index.
D
Sell
11/26/2021Upgraded
Remedent, Inc. (REMI) was upgraded to D+ from D on 11/26/2021 due to a large increase in the total return index, solvency index and volatility index.
Remedent, Inc. (REMI) was upgraded to D+ from D on 11/26/2021 due to a large increase in the total return index, solvency index and volatility index.
D
Sell
8/24/2021Downgrade
Remedent, Inc. (REMI) was downgraded to D from D+ on 8/24/2021 due to a decline in the volatility index and total return index.
Remedent, Inc. (REMI) was downgraded to D from D+ on 8/24/2021 due to a decline in the volatility index and total return index.
D
Sell
8/9/2021Upgraded
Remedent, Inc. (REMI) was upgraded to D+ from D on 8/9/2021 due to a noticeable increase in the total return index, volatility index and valuation index.
Remedent, Inc. (REMI) was upgraded to D+ from D on 8/9/2021 due to a noticeable increase in the total return index, volatility index and valuation index.
D
Sell
2/17/2021Downgrade
Remedent, Inc. (REMI) was downgraded to D from D+ on 2/17/2021 due to a decline in the growth index, efficiency index and valuation index. EBIT declined 76.51% from $61.3 to $14.4, and operating cash flow declined 27.74% from $94.8 to $68.5.
Remedent, Inc. (REMI) was downgraded to D from D+ on 2/17/2021 due to a decline in the growth index, efficiency index and valuation index. EBIT declined 76.51% from $61.3 to $14.4, and operating cash flow declined 27.74% from $94.8 to $68.5.
D
Sell
2/1/2021Upgraded
Remedent, Inc. (REMI) was upgraded to D+ from D on 2/1/2021 due to a noticeable increase in the total return index, growth index and volatility index. EBIT increased 483.81% from $10.5 to $61.3, operating cash flow increased 355.77% from $20.8 to $94.8, and earnings per share increased from $0.0001 to $0.0002.
Remedent, Inc. (REMI) was upgraded to D+ from D on 2/1/2021 due to a noticeable increase in the total return index, growth index and volatility index. EBIT increased 483.81% from $10.5 to $61.3, operating cash flow increased 355.77% from $20.8 to $94.8, and earnings per share increased from $0.0001 to $0.0002.
D
Sell
7/1/2020Downgrade
Remedent, Inc. (REMI) was downgraded to D from C- on 7/1/2020 due to a significant decline in the valuation index, growth index and efficiency index. Net income declined 141.75% from -$148.5 to -$359, earnings per share declined from -$0.01 to -$0.02, and EBIT declined 56.83% from -$123 to -$192.9.
Remedent, Inc. (REMI) was downgraded to D from C- on 7/1/2020 due to a significant decline in the valuation index, growth index and efficiency index. Net income declined 141.75% from -$148.5 to -$359, earnings per share declined from -$0.01 to -$0.02, and EBIT declined 56.83% from -$123 to -$192.9.
C
Hold
5/19/2020Downgrade
Remedent, Inc. (REMI) was downgraded to C- from C on 5/19/2020 due to a decline in the total return index.
Remedent, Inc. (REMI) was downgraded to C- from C on 5/19/2020 due to a decline in the total return index.
C
Hold
5/4/2020Upgraded
Remedent, Inc. (REMI) was upgraded to C from C- on 5/4/2020 due to an increase in the total return index, growth index and efficiency index.
Remedent, Inc. (REMI) was upgraded to C from C- on 5/4/2020 due to an increase in the total return index, growth index and efficiency index.
C
Hold
4/17/2020Downgrade
Remedent, Inc. (REMI) was downgraded to C- from C on 4/17/2020 due to a decline in the total return index and volatility index.
Remedent, Inc. (REMI) was downgraded to C- from C on 4/17/2020 due to a decline in the total return index and volatility index.
C
Hold
2/21/2020Upgraded
Remedent, Inc. (REMI) was upgraded to C from C- on 2/21/2020 due to an increase in the total return index and volatility index.
Remedent, Inc. (REMI) was upgraded to C from C- on 2/21/2020 due to an increase in the total return index and volatility index.
C
Hold
2/18/2020Upgraded
Remedent, Inc. (REMI) was upgraded to C- from D+ on 2/18/2020 due to a large increase in the growth index, volatility index and total return index. Operating cash flow increased 222.98% from -$45.7 to $56.2, and total revenue increased 8.26% from $242.1 to $262.1.
Remedent, Inc. (REMI) was upgraded to C- from D+ on 2/18/2020 due to a large increase in the growth index, volatility index and total return index. Operating cash flow increased 222.98% from -$45.7 to $56.2, and total revenue increased 8.26% from $242.1 to $262.1.
D
Sell
2/11/2020Downgrade
Remedent, Inc. (REMI) was downgraded to D+ from C- on 2/11/2020 due to a decline in the volatility index.
Remedent, Inc. (REMI) was downgraded to D+ from C- on 2/11/2020 due to a decline in the volatility index.
C
Hold
1/27/2020Upgraded
Remedent, Inc. (REMI) was upgraded to C- from D+ on 1/27/2020 due to an increase in the volatility index and total return index.
Remedent, Inc. (REMI) was upgraded to C- from D+ on 1/27/2020 due to an increase in the volatility index and total return index.
D
Sell
8/19/2019Downgrade
Remedent, Inc. (REMI) was downgraded to D+ from C on 8/19/2019 due to a noticeable decline in the growth index, volatility index and total return index. Earnings per share declined from $0.1265 to -$0.0096, operating cash flow declined 95.83% from $589.6 to $24.6, and total revenue declined 23.25% from $403.9 to $310.
Remedent, Inc. (REMI) was downgraded to D+ from C on 8/19/2019 due to a noticeable decline in the growth index, volatility index and total return index. Earnings per share declined from $0.1265 to -$0.0096, operating cash flow declined 95.83% from $589.6 to $24.6, and total revenue declined 23.25% from $403.9 to $310.
C
Hold
8/14/2019Upgraded
Remedent, Inc. (REMI) was upgraded to C from C- on 8/14/2019 due to an increase in the volatility index.
Remedent, Inc. (REMI) was upgraded to C from C- on 8/14/2019 due to an increase in the volatility index.
C
Hold
7/19/2019Downgrade
Remedent, Inc. (REMI) was downgraded to C- from C on 7/19/2019 due to a decline in the volatility index and total return index.
Remedent, Inc. (REMI) was downgraded to C- from C on 7/19/2019 due to a decline in the volatility index and total return index.
C
Hold
7/1/2019Upgraded
Remedent, Inc. (REMI) was upgraded to C from D on 7/1/2019 due to a significant increase in the valuation index, efficiency index and growth index. Operating cash flow increased 7,557.14% from $7.7 to $589.6, net income increased 1,458.63% from -$187.8 to $2.55M, and earnings per share increased from -$0.01 to $0.04.
Remedent, Inc. (REMI) was upgraded to C from D on 7/1/2019 due to a significant increase in the valuation index, efficiency index and growth index. Operating cash flow increased 7,557.14% from $7.7 to $589.6, net income increased 1,458.63% from -$187.8 to $2.55M, and earnings per share increased from -$0.01 to $0.04.
D
Sell
2/15/2019Downgrade
Remedent, Inc. (REMI) was downgraded to D from D+ on 2/15/2019 due to a noticeable decline in the efficiency index, growth index and solvency index. Earnings per share declined from -$0.0038 to -$0.01, net income declined 146.46% from -$76.2 to -$187.8, and EBIT declined 97.51% from -$112.6 to -$222.4.
Remedent, Inc. (REMI) was downgraded to D from D+ on 2/15/2019 due to a noticeable decline in the efficiency index, growth index and solvency index. Earnings per share declined from -$0.0038 to -$0.01, net income declined 146.46% from -$76.2 to -$187.8, and EBIT declined 97.51% from -$112.6 to -$222.4.
D
Sell
2/11/2019Upgraded
Remedent, Inc. (REMI) was upgraded to D+ from D on 2/11/2019 due to an increase in the total return index, volatility index and valuation index.
Remedent, Inc. (REMI) was upgraded to D+ from D on 2/11/2019 due to an increase in the total return index, volatility index and valuation index.
D
Sell
1/23/2019Downgrade
Remedent, Inc. (REMI) was downgraded to D from D+ on 1/23/2019 due to a decline in the volatility index and valuation index.
Remedent, Inc. (REMI) was downgraded to D from D+ on 1/23/2019 due to a decline in the volatility index and valuation index.
D
Sell
12/13/2018Upgraded
Remedent, Inc. (REMI) was upgraded to D+ from D on 12/13/2018 due to an increase in the volatility index and total return index.
Remedent, Inc. (REMI) was upgraded to D+ from D on 12/13/2018 due to an increase in the volatility index and total return index.
D
Sell
11/28/2018Downgrade
Remedent, Inc. (REMI) was downgraded to D from D+ on 11/28/2018 due to a noticeable decline in the efficiency index, total return index and volatility index. Total capital declined 2.69% from $3.17M to $3.09M.
Remedent, Inc. (REMI) was downgraded to D from D+ on 11/28/2018 due to a noticeable decline in the efficiency index, total return index and volatility index. Total capital declined 2.69% from $3.17M to $3.09M.
D
Sell
7/13/2018Downgrade
Remedent, Inc. (REMI) was downgraded to D+ from C on 7/13/2018 due to a significant decline in the valuation index, total return index and efficiency index. Net income declined 520.15% from $52.1 to -$218.9, and total capital declined 1.81% from $3.37M to $3.31M.
Remedent, Inc. (REMI) was downgraded to D+ from C on 7/13/2018 due to a significant decline in the valuation index, total return index and efficiency index. Net income declined 520.15% from $52.1 to -$218.9, and total capital declined 1.81% from $3.37M to $3.31M.
C
Hold
5/4/2017None
Remedent, Inc. (REMI) was downgraded to C from U on 05/04/2017.
Remedent, Inc. (REMI) was downgraded to C from U on 05/04/2017.
OTC PK
03/03/2025 2:44PM Eastern
Quotes delayed
